Search Results
Dec 18, 2025, 08:45 ET PANTHERx® Rare Selected by Otsuka to Dispense VOYXACT® (sibeprenlimab-szsi) for the Treatment of Primary Immunoglobulin A Nephropathy
U.S. territories and was the first national pharmacy to achieve dual accreditations in rare disease from the Accreditation Commission for Health Care (ACHC) and Utilization Review Accreditation Commission (URAC). PANTHERx is also the eight-time winner of the prestigious MMIT Patient Choice Award for patient
More news about: PANTHERx Rare Pharmacy
Dec 16, 2025, 09:06 ET Orsini Names Ashley Keller as Chief People Officer
patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini
Dec 08, 2025, 10:31 ET BioMatrix Infusion Pharmacy Expands Western U.S. Footprint with Acquisition of Total Infusion Care
prioritizes safety, comfort, and superior clinical outcomes. The organization is proudly accredited by the Accreditation Commission for Health Care (ACHC), reflecting its commitment to the highest standards of quality and performance in patient care. For more information about Total Infusion Care, please
More news about: BioMatrix Infusion Pharmacy
Dec 08, 2025, 08:00 ET Orsini and Dos Rx partner to support international medical travel facilitation
personalized patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Certification and ACHC's Distinction in Rare
More news about: Orsini
Dec 02, 2025, 08:00 ET Orsini Selected as Specialty Pharmacy Partner for ITVISMA® (onasemnogene abeparvovec-brve)
patient care to ensure that No Patient is Left Behind™.Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini
Oct 28, 2025, 12:26 ET Rx To Go Achieves Accreditation with ACHC
Accreditation by ACHC reflects an organization's dedication and commitment to meeting standards that facilitate a higher level of performance and patient care. ACHC is a nonprofit organization that has stood as a symbol of quality and excellence since 1986. ACHC is ISO 9001:2015
More news about: Florida Cancer Specialists & Research Institute
Oct 20, 2025, 09:37 ET Orsini Launches Integrated Specialty Pharmacy and 3PL Solution at Columbus, Ohio Facility
ensure that No Patient is Left Behind™. Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini
Oct 15, 2025, 12:44 ET Florida Cancer Specialists & Research Institute Champions the Impact of Integrated Oncology At NCODA International Summit
personalized support to patients receiving oral chemotherapy. It is accredited by URAC for Specialty Pharmacy, Accreditation Commission for Health Care (ACHC) with Oncology Distinction, and dually accredited by the National Association of Boards of Pharmacy® (NABP®) for specialty pharmacy
More news about: Florida Cancer Specialists & Research Institute
Oct 14, 2025, 13:04 ET Alora Healthcare Systems Earns ACHC Product Certification for Home Health, Home Care, and Hospice Software
high-quality system," said Susan Mills, ACHC Senior Program Director. "ACHC Product Certification was designed to build understanding of the accreditation requirements for the settings in which these products are used and to support ACHC customers by providing a simple way to validate
More news about: Alora Healthcare Systems
Oct 14, 2025, 08:00 ET Orsini Selected as Specialty Pharmacy Partner for Boehringer Ingelheim's JASCAYD® (nerandomilast)
ensure that No Patient is Left Behind™. Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini
Oct 13, 2025, 11:11 ET PANTHERx® Rare Selected by Chiesi for the Distribution of MYCAPSSA®
PANTHERx is a dual-accredited specialty pharmacy, with notable distinctions in rare diseases, including the Accreditation Commission for Health Care (ACHC) Distinction in Orphan Drugs and Utilization Review Accreditation Commission (URAC) Rare Disease Center of Excellence. As a pharmacy focused on patient
More news about: PANTHERx Rare Pharmacy
Sep 26, 2025, 08:00 ET Orsini Selected as Specialty Pharmacy Partner for Crinetics' PALSONIFY™ (paltusotine)
patient care to ensure that No Patient is Left Behind™. Orsini holds accreditations with the Accreditation Commission for Health Care (ACHC), The Joint Commission, URAC and NABP. Orsini has earned URAC's Rare Disease Pharmacy Center of Excellence Designation and ACHC's Distinction in Rare Diseases
More news about: Orsini